INTERLEUKIN-17 INHIBITORS

The present invention relates to novel pyridine-N oxide substituted 2-formamido (N-phenyl and N-pyridyl) acetamide compounds that are Interleukin-17 (IL-17) inhibitors, processes for their preparation, pharmaceutical compositions, and medicaments containing them, and their use in diseases and disord...

Full description

Saved in:
Bibliographic Details
Main Authors TROXLER, THOMAS JOSEF, FURET, PASCAL, ORAIN, DAVID, WEIGAND, KLAUS, SCHLAPBACH, ACHIM
Format Patent
LanguageEnglish
French
Published 05.05.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel pyridine-N oxide substituted 2-formamido (N-phenyl and N-pyridyl) acetamide compounds that are Interleukin-17 (IL-17) inhibitors, processes for their preparation, pharmaceutical compositions, and medicaments containing them, and their use in diseases and disorders mediated by IL-17. La présente invention concerne de nouveaux composés de 2-formamido (N-phényle et N-pyridyle) acétamide substitués par un oxyde de pyridine-N qui sont des inhibiteurs de l'interleukine-17 (IL-17), des procédés pour leur préparation, des compositions pharmaceutiques et des médicaments les contenant, ainsi que leur utilisation dans des maladies et des troubles médiés par IL-17.
Bibliography:Application Number: CA20213190738